Rare diseases
Investigational molecules
Locations
Back to Sweden376 clinical trials in Gothenburg, Sweden across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SwedenKliniska-Provningar.se(opens in a new tab)Study on Roxadustat for Treating Anemia in Children with Chronic Kidney Disease
SwedenStudy on Conditioning Treatments with Busulfan, Clofarabine, and Fludarabine for Children with Acute Myeloid Leukemia Undergoing Stem Cell Transplantation
SwedenStudy on Glioblastoma Recurrence: Comparing SonoCloud-9 with Carboplatin to Standard Treatments Lomustine or Temozolomide for Patients Undergoing Tumor Removal Surgery
SwedenStudy on Psilocybin for Treating Depression in Cancer Patients
SwedenStudy on Upadacitinib and Tocilizumab for Children and Teens with Active Systemic Juvenile Idiopathic Arthritis
SwedenSwedenStudy Comparing Telisotuzumab Vedotin and Docetaxel for Adults with Previously Treated Non-Squamous Non-Small Cell Lung Cancer
SwedenStudy on the Effectiveness and Safety of Lifileucel and Pembrolizumab for Patients with Untreated, Unresectable, or Metastatic Melanoma
SwedenStudy on the Safety and Effectiveness of Quizartinib for Children with Newly Diagnosed FLT3-ITD Positive AML and Normal NPM1
SwedenStudy on Crohn's Disease: Evaluating Risankizumab's Effects in Children Aged 2 to 17 with Moderate to Severe Symptoms
SwedenStudy on Dapagliflozin for Reducing Atrial Fibrillation and Kidney Injury in Patients Awaiting Coronary Artery Bypass Surgery
SwedenStudy on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease
SwedenThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on innovative treatments for various types of leukemia, including chronic lymphocytic leukemia and acute myeloid leukemia. Studies are evaluating new therapeutic combinations and treatment approaches for lymphoma and pediatric cancers.
Advanced research into targeted therapies and personalized treatment protocols for better patient outcomes.
Groundbreaking studies on rare genetic conditions including Niemann-Pick disease and gangliosidoses. Research focuses on evaluating novel treatments and investigating long-term outcomes for mucopolysaccharidosis and other rare disorders.
Innovative approaches to addressing complex rare diseases with targeted therapeutic interventions.
Comprehensive research into cardiovascular disease prevention and treatment, alongside studies on various kidney conditions. Trials evaluating new medications for stroke prevention in atrial fibrillation and treatments for glomerular diseases.
Focus on developing effective treatments for both common and rare cardiovascular and renal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
